Entrada Therapeutics, Inc.
TRDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $65,626 | -$6,685 | -$94,616 | -$51,158 |
| Dep. & Amort. | $3,773 | $2,841 | $1,895 | $1,117 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $17,915 | $13,111 | $0 | $2,526 |
| Change in WC | -$118,853 | $136,315 | -$11,111 | -$3,421 |
| Other Non-Cash | -$10,018 | -$5,779 | $10,046 | $74 |
| Operating Cash Flow | -$41,557 | $139,803 | -$93,786 | -$50,862 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,158 | -$5,614 | -$2,887 | -$4,580 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$437,717 | -$407,207 | -$221,977 | $0 |
| Inv. Sales/Matur. | $413,077 | $274,426 | $76,214 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$27,798 | -$138,395 | -$148,650 | -$4,580 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $99,608 | $19,407 | $479 | $190,691 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,356 | $1,630 | $0 | $116,770 |
| Financing Cash Flow | $102,964 | $21,037 | $479 | $307,461 |
| Forex Effect | $0 | $0 | -$3,950 | $0 |
| Net Chg. in Cash | $33,609 | $22,445 | -$245,907 | $252,019 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $71,552 | $49,107 | $291,064 | $39,045 |
| End Cash | $105,161 | $71,552 | $45,157 | $291,064 |
| Free Cash Flow | -$44,715 | $134,189 | -$96,673 | -$55,442 |